Literature DB >> 7403682

Prevention of hemoglobinuria by administration of haptoglobin.

T U Ohshiro, K Mukai, G Kosaki.   

Abstract

This report describes the role of haptoglobin in preventing hemoglobinuria. In rabbits, human haptoglobin administered i.v. worked preventively against the development of hemoglobinuria in spite of the presence of a large amount of hemolysate containing free hemoglobin. More specifically: (1) the kidney did not present a dark brown color, (2) the deposition of iron in the kidney was significantly less than that in the same organ of rabbits given hemolysate only, and (3) the microangiographic and histological findings of the kidney were close to normal patterns. From the above it may be concluded that the administration of haptoglobin is effective for the prevention of hemoglobinuria and subsequent renal damage.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7403682     DOI: 10.1007/bf01851626

Source DB:  PubMed          Journal:  Res Exp Med (Berl)        ISSN: 0300-9130


  3 in total

1.  Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy.

Authors:  Jin Hyen Baek; Felice D'Agnillo; Florence Vallelian; Claudia P Pereira; Matthew C Williams; Yiping Jia; Dominik J Schaer; Paul W Buehler
Journal:  J Clin Invest       Date:  2012-03-26       Impact factor: 14.808

2.  Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs.

Authors:  Felicitas S Boretti; Paul W Buehler; Felice D'Agnillo; Katharina Kluge; Tony Glaus; Omer I Butt; Yiping Jia; Jeroen Goede; Claudia P Pereira; Marco Maggiorini; Gabriele Schoedon; Abdu I Alayash; Dominik J Schaer
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

Review 3.  The Complex Relationship of Extracorporeal Membrane Oxygenation and Acute Kidney Injury: Causation or Association?

Authors:  Daniel J Kilburn; Kiran Shekar; John F Fraser
Journal:  Biomed Res Int       Date:  2016-02-24       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.